Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
暂无分享,去创建一个
C. Fulco | I. Ghobrial | Rockwell Anyoha | D. Rausch | Aishwarya Gurumurthy | R. Kodgule | M. Cieslik | J. Engreitz | M. Rahmat | Travis Saari | Juhi Gupta | R. Ryan | John S. Runge | Cody N Hall | Athalee R Aguilar | Ashwin Iyer | Abdullah Ramzan | Matthew Weiss
[1] Michael G. Kharas,et al. BTG1 mutation yields supercompetitive B cells primed for malignant transformation , 2023, Science.
[2] M. Chiang,et al. ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia. , 2022, Blood cancer discovery.
[3] Patrick C. Fiaux,et al. Systematic discovery and functional dissection of enhancers needed for cancer cell fitness and proliferation , 2022, Cell reports.
[4] Lei S. Qi,et al. Nested epistasis enhancer networks for robust genome regulation , 2022, Science.
[5] Ryan D. Morin,et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma , 2022, Nature.
[6] G. Ciriello,et al. Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci , 2021, Nature Genetics.
[7] Lisa E. Wagar,et al. Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci , 2021, bioRxiv.
[8] O. Elemento,et al. Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. , 2020, Molecular cell.
[9] M. Yaspo,et al. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. , 2019, Cancer cell.
[10] Ryan D. Morin,et al. --The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. , 2019, Blood.
[11] Neva C. Durand,et al. Activity-by-Contact model of enhancer-promoter regulation from thousands of CRISPR perturbations , 2019, Nature Genetics.
[12] Ryan D. Morin,et al. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Barrans,et al. Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Kendall R. Sanson,et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities , 2018, Nature Communications.
[15] Ryan D. Morin,et al. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. , 2018, Blood advances.
[16] Stefano Monti,et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.
[17] Roland Schmitz,et al. Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.
[18] Andreas Trumpp,et al. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies , 2018, Nature.
[19] Shawn M. Gillespie,et al. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. , 2017, Cell reports.
[20] A. McKenna,et al. FlashFry: a fast and flexible tool for large-scale CRISPR target design , 2017, bioRxiv.
[21] Phillip G. Montgomery,et al. Defining a Cancer Dependency Map , 2017, Cell.
[22] R. Dalla‐Favera,et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia , 2017, Proceedings of the National Academy of Sciences.
[23] Sharon R Grossman,et al. Systematic mapping of functional enhancer–promoter connections with CRISPR interference , 2016, Science.
[24] Olivier Elemento,et al. Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region. , 2016, Immunity.
[25] David M Sabatini,et al. Single Guide RNA Library Design and Construction. , 2016, Cold Spring Harbor protocols.
[26] A. Sabò,et al. MYC: connecting selective transcriptional control to global RNA production , 2015, Nature Reviews Cancer.
[27] Shawn M. Gillespie,et al. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. , 2015, Cancer discovery.
[28] S. Spicuglia,et al. [The European Blueprint project: towards a full epigenome characterization of the immune system]. , 2015, Medecine sciences : M/S.
[29] Yijun Ruan,et al. B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity , 2014, Cell.
[30] Jun S. Liu,et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.
[31] Paolo Vineis,et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.
[32] Teresa Palomero,et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia , 2014, Nature Medicine.
[33] R. Spang,et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. , 2014, Blood.
[34] Ming Yu,et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation , 2013, Genes & development.
[35] M. Nussenzweig,et al. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry , 2012, Nature Immunology.
[36] Amos Tanay,et al. Robust 4C-seq data analysis to screen for regulatory DNA interactions , 2012, Nature Methods.
[37] A. Ashworth,et al. A genome-wide association study of Hodgkin Lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21, and 10p14 (GATA3) , 2010, Nature Genetics.
[38] W. Chan,et al. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells , 2010, Proceedings of the National Academy of Sciences.
[39] G. K. Davis,et al. Phenotypic robustness conferred by apparently redundant transcriptional enhancers , 2010, Nature.
[40] E. Campo,et al. Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.
[41] F. Alt,et al. Long-range Oncogenic Activation of IgH/c-myc Translocations by the IgH 3’ Regulatory Region , 2009, Nature.
[42] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[43] Katia Basso,et al. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. , 2003, Blood.
[44] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[45] M. Neuberger,et al. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus , 1990, Nature.
[46] J. Banerji,et al. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes , 1983, Cell.